LEADER 00921nam0-22003491i-450 
001 990001638680403321
005 20200309152943.0
035   $a000163868
035   $aFED01000163868
035   $a(Aleph)000163868FED01
035   $a000163868
100   $a20030910d1983----km-y0itay50------ba
101 0 $aita
102   $aIT
105   $aa       001yy
200 1 $aManuale del lombricoltore$fCarlo Ferruzzi
210   $aBologna$cEdagricole$d1983
215   $aV, 121 p.$cill.$d26 cm
610 0 $aLombricoltura
610 0 $aLombrichi
676   $a639.754 6
676   $a639.75$v23$zita
700  1$aFerruzzi,$bCarlo$070244
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990001638680403321
952   $a636.5-23$b8239$fDMVBF
952   $a60 639.75 FERC 1983$b48486$fFAGBC
959   $aFAGBC
959   $aDMVBF
996   $aManuale del lombricoltore$9367724
997   $aUNINA

LEADER 03601nam  22006975  450 
001 9910298314303321
005 20200704123920.0
010   $a94-017-8035-8
024 7 $a10.1007/978-94-017-8035-3
035   $a(CKB)3710000000084238
035   $a(EBL)1636844
035   $a(OCoLC)871044368
035   $a(SSID)ssj0001152608
035   $a(PQKBManifestationID)11682032
035   $a(PQKBTitleCode)TC0001152608
035   $a(PQKBWorkID)11149429
035   $a(PQKB)11262650
035   $a(MiAaPQ)EBC1636844
035   $a(DE-He213)978-94-017-8035-3
035   $a(PPN)176130608
035   $a(EXLCZ)993710000000084238
100   $a20140106d2014      u|         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aAngiogenesis and Anti-Angiogenesis in Hematological Malignancies /$fby Domenico Ribatti
205   $a1st ed. 2014.
210  1$aDordrecht :$cSpringer Netherlands :$cImprint: Springer,$d2014.
215   $a1 online resource (118 p.)
300   $aDescription based upon print version of record.
311   $a94-017-8034-X 
320   $aIncludes bibliographical references and index.
327   $aPreface -- Introduction -- Angiogenesis in multiple myeloma -- Angiogenesis in lymphomas -- Angiogenesis in leukemia -- Antiangiogenesis -- Concluding remarks -- References.
330   $aIt has been generally accepted that angiogenesis is involved in the pathogenesis of hematological malignancies, like acute and chronic leukemia, lymphoma, myelodysplastic syndromes, myeloproliferative neoplasms and multiple myeloma. The extent of angiogenesis in the bone marrow has been correlated with disease burden, prognosis and treatment outcome. Reciprocal positive and negative interactions between tumor cells and bone marrow stromal cells, namely hematopoietic stem cells, fibroblasts, osteoblasts/osteoclasts, endothelial cells, endothelial progenitor cells, T cells, macrophages and mast cells, mediated by an array of cytokines, receptors and adhesion molecules, modulate the angiogenic response in hematological tumors. More recently, it has been emphasized the pro-angiogenic role of the so called ?vascular niche?, indicating a site rich in blood vessels where endothelial cells and mural cells such as pericytes and smooth muscle cells create a microenvironment that affects the behavior of several stem and progenitor cells, in hematological malignancies.
606   $aCancer$xResearch
606   $aOncology
606   $aHematology
606   $aLife sciences
606   $aCancer Research$3https://scigraph.springernature.com/ontologies/product-market-codes/B11001
606   $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160
606   $aHematology$3https://scigraph.springernature.com/ontologies/product-market-codes/H3307X
606   $aLife Sciences, general$3https://scigraph.springernature.com/ontologies/product-market-codes/L00004
615  0$aCancer$xResearch.
615  0$aOncology.
615  0$aHematology.
615  0$aLife sciences.
615 14$aCancer Research.
615 24$aOncology.
615 24$aHematology.
615 24$aLife Sciences, general.
676   $a570
676   $a599.017
676   $a599/.017
700   $aRibatti$b Domenico$4aut$4http://id.loc.gov/vocabulary/relators/aut$0793065
712 02$aEuropean Union.
906   $aBOOK
912   $a9910298314303321
996   $aAngiogenesis and Anti-Angiogenesis in Hematological Malignancies$92502661
997   $aUNINA